Pzena Investment Management LLC Decreases Holdings in Teleflex Incorporated $TFX

Pzena Investment Management LLC lessened its stake in shares of Teleflex Incorporated (NYSE:TFX) by 2.1% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 379,465 shares of the medical technology company’s stock after selling 8,018 shares during the quarter. Pzena Investment Management LLC’s holdings in Teleflex were worth $46,310,000 as of its most recent filing with the SEC.

A number of other large investors have also added to or reduced their stakes in TFX. Banque Cantonale Vaudoise increased its holdings in Teleflex by 82.5% during the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock worth $31,000 after buying an additional 113 shares during the last quarter. Hantz Financial Services Inc. increased its holdings in Teleflex by 248.8% during the third quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock worth $34,000 after buying an additional 199 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. purchased a new stake in Teleflex during the third quarter worth about $35,000. V Square Quantitative Management LLC purchased a new stake in Teleflex during the fourth quarter worth about $37,000. Finally, Cullen Frost Bankers Inc. increased its holdings in Teleflex by 496.7% during the third quarter. Cullen Frost Bankers Inc. now owns 358 shares of the medical technology company’s stock worth $44,000 after buying an additional 298 shares during the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

TFX opened at $131.77 on Friday. The company has a market capitalization of $5.83 billion, a price-to-earnings ratio of -5.78, a PEG ratio of 1.01 and a beta of 0.82. The company has a quick ratio of 2.03, a current ratio of 2.55 and a debt-to-equity ratio of 0.82. The firm has a 50-day moving average price of $122.22 and a 200-day moving average price of $116.82. Teleflex Incorporated has a twelve month low of $100.18 and a twelve month high of $139.67.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, May 7th. The medical technology company reported $1.39 earnings per share for the quarter, topping the consensus estimate of $1.21 by $0.18. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The firm had revenue of $548.30 million during the quarter, compared to the consensus estimate of $536.91 million. During the same quarter last year, the company earned $1.44 earnings per share. The company’s revenue was up 32.3% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Equities analysts expect that Teleflex Incorporated will post 6.7 EPS for the current year.

Teleflex Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Monday, May 25th will be given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Friday, May 22nd. Teleflex’s dividend payout ratio (DPR) is -5.96%.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on TFX. Wall Street Zen downgraded shares of Teleflex from a “hold” rating to a “sell” rating in a report on Saturday, May 9th. Raymond James Financial reiterated an “outperform” rating and issued a $150.00 target price on shares of Teleflex in a research note on Friday, May 8th. Wells Fargo & Company lifted their target price on shares of Teleflex from $130.00 to $138.00 and gave the stock an “equal weight” rating in a research note on Friday, May 8th. Royal Bank Of Canada upgraded shares of Teleflex from a “sector perform” rating to an “outperform” rating and lifted their target price for the stock from $135.00 to $155.00 in a research note on Friday, May 8th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Teleflex in a research note on Friday, March 27th. Three analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $144.00.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.